
FDA Approves FoundationOne CDx for Tepotinib in MET+ NSCLC
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNZS14bmVQOHM1aWlCXzFwM0EydWhTOXJaMW9kamVzOGNuTTZNOHM3S0dvYTlEb2d4VzlJTERfTjN4TWY2VFhkRGZubC0zTlFXamJUZjZacnM3dXRTSjJBZkNfaEJ4VHF1eUVWZTFzLXE2T0FrLXhDN21Ja0ZpcXlYNmVyUG5IRUdqd3BMMXVPY1o1THBzejdn?oc=5" target="_blank">FDA Approves FoundationOne CDx for Tepotinib in MET+ NSCLC</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>

